StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2018 it was -3153.7%, against -252.4% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 2018-3153.7%−2901.2
FY2017Dec 31, 2017-252.4%–

More Oncolytics Biotech figures

See a number that looks wrong?